Other Species / Isoforms
  CABLES1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R107-m1
GACGARTrFsLLAAA
0 1
CABLES1 (human) GACGARTrFsLLAAA R107-m1
CABLES1 (mouse) TKPGARARLSLLAAG R96
CABLES1 (rat) AKPGARARFSLLAAG R45
S109-p
CGARTrFsLLAAAER
0 1
CABLES1 (human) CGARTrFsLLAAAER S109-p
CABLES1 (mouse) PGARARLSLLAAGCN S98
CABLES1 (rat) PGARARFSLLAAGCN S47
S168-p
GVARGFAsPLGAGRA
Upstream
0 12
Treatment
  • MG132_withdrawal
CABLES1 (human) GVARGFAsPLGAGRA S168-p
CABLES1 (mouse) gap -
CABLES1 (rat) gap -
S242-p
GSRGRLNsFtQGILP
Upstream
1 34
Treatment
  • imatinib
  • Su11274
  • wortmannin
CABLES1 (human) GSRGRLNsFtQGILP S242-p
CABLES1 (mouse) GSRGRLNsFTQGILP S203-p
CABLES1 (rat) GSRGRLNSFTQGILP S152
T244-p
RGRLNsFtQGILPIA
0 3
CABLES1 (human) RGRLNsFtQGILPIA T244-p
CABLES1 (mouse) RGRLNsFTQGILPIA T205
CABLES1 (rat) RGRLNSFTQGILPIA T154
S257-p
IAFSRPTsQNyCsLE
0 1
CABLES1 (human) IAFSRPTsQNyCsLE S257-p
CABLES1 (mouse) IAFSRQNSQNYCALE S218
CABLES1 (rat) IAFSRQNSQNYCALE S167
Y260-p
SRPTsQNyCsLEQPG
Upstream
0 19
Treatment
  • Su11274
CABLES1 (human) SRPTsQNyCsLEQPG Y260-p
CABLES1 (mouse) SRQNSQNYCALEQSG Y221
CABLES1 (rat) SRQNSQNYCALEQSG Y170
S262-p
PTsQNyCsLEQPGQG
0 2
CABLES1 (human) PTsQNyCsLEQPGQG S262-p
CABLES1 (mouse) QNSQNYCALEQSGQG A223
CABLES1 (rat) QNSQNYCALEQSGQG A172
S287-p
RSRRRLIsQRssLEt
0 15
CABLES1 (human) RSRRRLIsQRssLEt S287-p
CABLES1 (mouse) RSRRRLIsQRssLEt S248-p
CABLES1 (rat) RSRRRLISQRSsLET S197
S290-p
RRLIsQRssLEtLED
Upstream
0 8
Treatment
  • ischemia
CABLES1 (human) RRLIsQRssLEtLED S290-p
CABLES1 (mouse) RRLIsQRssLEtLED S251-p
CABLES1 (rat) RRLISQRSsLETLED S200
S291-p
RLIsQRssLEtLEDI
0 16
CABLES1 (human) RLIsQRssLEtLEDI S291-p
CABLES1 (mouse) RLIsQRssLEtLEDI S252-p
CABLES1 (rat) RLISQRSsLETLEDI S201-p
T294-p
sQRssLEtLEDIEEN
Upstream
0 5
Treatment
  • MG132
CABLES1 (human) sQRssLEtLEDIEEN T294-p
CABLES1 (mouse) sQRssLEtLEDIEEN T255-p
CABLES1 (rat) SQRSsLETLEDIEEN T204
T309-p
APLRRCRtLsGsPRP
Upstream
Downstream
1 11
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • transcription, altered
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • Akt-I-1,2
  • IGF-1
  • INK-128
  • LY294002
  • SB216763
CABLES1 (human) APLRRCRtLsGsPRP T309-p
CABLES1 (mouse) APLRRCRtLsGsPRP T270-p
CABLES1 (rat) APLRRCRTLSGSPRP T219
S311-p
LRRCRtLsGsPRPKN
0 13
CABLES1 (human) LRRCRtLsGsPRPKN S311-p
CABLES1 (mouse) LRRCRtLsGsPRPKN S272-p
CABLES1 (rat) LRRCRTLSGSPRPEN S221
S313-p
RCRtLsGsPRPKNFK
Upstream
1 12
Kinase, in vitro:
  • CDK3 (human)
Putative in vivo kinases:
  • CDK3 (human)
CABLES1 (human) RCRtLsGsPRPKNFK S313-p
CABLES1 (mouse) RCRtLsGsPRPKNFK S274-p
CABLES1 (rat) RCRTLSGSPRPENFK S223
T333-p
KNMRQHDtRNGRIVL
0 1
CABLES1 (human) KNMRQHDtRNGRIVL T333-p
CABLES1 (mouse) KNMRQHDTKNGRDLK T294
CABLES1 (rat) KNMRQHDTRNGRDLK T243
S373-p
KLDGGRQsTGAVsLK
0 7
CABLES1 (human) KLDGGRQsTGAVsLK S373-p
CABLES1 (mouse) KLDGGRQsAGAMsLK S308-p
CABLES1 (rat) KLDGGRQSAGAMSLK S257
S378-p
RQsTGAVsLKEIIGL
0 6
CABLES1 (human) RQsTGAVsLKEIIGL S378-p
CABLES1 (mouse) RQsAGAMsLKEIIGL S313-p
CABLES1 (rat) RQSAGAMSLKEIIGL S262
T396
ELGADGKTVSYTQFL
0 1
CABLES1 (human) ELGADGKTVSYTQFL T396
CABLES1 (mouse) ELGADGKTVSYTQFL T331
CABLES1 (rat) ELGADGKtVSyTQFL T280-p
Y399
ADGKTVSYTQFLLPT
0 1
CABLES1 (human) ADGKTVSYTQFLLPT Y399
CABLES1 (mouse) ADGKTVSYTQFLLPT Y334
CABLES1 (rat) ADGKtVSyTQFLSPT Y283-p
A411
LPTNAFGARRNtIDs
0 1
CABLES1 (human) LPTNAFGARRNtIDs A411
CABLES1 (mouse) LPTNAFGNRRNtIDs N346
CABLES1 (rat) SPTNAFGtRRNtIDS T295-p
T415-p
AFGARRNtIDstSsF
Upstream
Downstream
1 96
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • transcription, altered
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • Akt-I-1,2
  • IGF-1
  • INK-128
  • LY294002
  • rapamycin
  • SB216763
CABLES1 (human) AFGARRNtIDstSsF T415-p
CABLES1 (mouse) AFGNRRNtIDsTAsF T350-p
CABLES1 (rat) AFGtRRNtIDSTsSF T299-p
S418-p
ARRNtIDstSsFSQF
0 11
CABLES1 (human) ARRNtIDstSsFSQF S418-p
CABLES1 (mouse) NRRNtIDsTAsFSQF S353-p
CABLES1 (rat) tRRNtIDSTsSFSQF S302
T419-p
RRNtIDstSsFSQFR
0 2
CABLES1 (human) RRNtIDstSsFSQFR T419-p
CABLES1 (mouse) RRNtIDsTAsFSQFR T354
CABLES1 (rat) RRNtIDSTsSFSQFR T303
S420
RNtIDstSsFSQFRN
0 1
CABLES1 (human) RNtIDstSsFSQFRN S420
CABLES1 (mouse) RNtIDsTAsFSQFRS A355
CABLES1 (rat) RNtIDSTsSFSQFRS S304-p
S421-p
NtIDstSsFSQFRNL
0 2
CABLES1 (human) NtIDstSsFSQFRNL S421-p
CABLES1 (mouse) NtIDsTAsFSQFRSL S356-p
CABLES1 (rat) NtIDSTsSFSQFRSL S305
S429-p
FSQFRNLsHRsLsIG
0 4
CABLES1 (human) FSQFRNLsHRsLsIG S429-p
CABLES1 (mouse) FSQFRSLsHRsLsMG S364-p
CABLES1 (rat) FSQFRSLSHRSLSMG S313
S432-p
FRNLsHRsLsIGRAS
0 5
CABLES1 (human) FRNLsHRsLsIGRAS S432-p
CABLES1 (mouse) FRSLsHRsLsMGRAG S367-p
CABLES1 (rat) FRSLSHRSLSMGRTG S316
S434-p
NLsHRsLsIGRASGT
0 8
CABLES1 (human) NLsHRsLsIGRASGT S434-p
CABLES1 (mouse) SLsHRsLsMGRAGsT S369-p
CABLES1 (rat) SLSHRSLSMGRTGST S318
G440
LsIGRASGTQGSLDT
0 1
CABLES1 (human) LsIGRASGTQGSLDT G440
CABLES1 (mouse) LsMGRAGsTQGsLDA S375-p
CABLES1 (rat) LSMGRTGSTQGSLDA S324
S444
RASGTQGSLDTGSDL
0 1
CABLES1 (human) RASGTQGSLDTGSDL S444
CABLES1 (mouse) RAGsTQGsLDAGsDL S379-p
CABLES1 (rat) RTGSTQGSLDAGNDL S328
S449
QGSLDTGSDLGDFMD
0 1
CABLES1 (human) QGSLDTGSDLGDFMD S449
CABLES1 (mouse) QGsLDAGsDLGDFMD S384-p
CABLES1 (rat) QGSLDAGNDLGDFID N333
S575-p
LLAAKIGsDLKKHEV
0 1
CABLES1 (human) LLAAKIGsDLKKHEV S575-p
CABLES1 (mouse) LLAAKVGSDLRKHEV S510
CABLES1 (rat) LLAAKVGSDLKKHEV S459